Jerome Kim
Jerome Hahn Kim is Director General of the International Vaccine Institute (IVI).[1][2]
He was educated at University of Hawaiʻi at Mānoa where he studied Biology and History, the Yale School of Medicine (MD, 1984), and completed his training at Duke University Medical Center.[3][4] Prior to IVI, Dr. Kim led the US Army's advanced development program for HIV vaccines, the RV 144 HIV vaccine trial, and a molecular virology laboratory at Walter Reed Army Institute of Research.[3]
He has an h-index of 76 according to Google Scholar.[5]
References
- ^ Ledford, Heidi (2021). "Why COVID vaccines are so difficult to compare". Nature. 591 (7848): 16–17. Bibcode:2021Natur.591...16L. doi:10.1038/d41586-021-00409-0. PMID 33623151. S2CID 232039872. Retrieved 15 July 2021.
- ^ "India's Covid Curve Could Raise the World's". The Wall Street Journal. Retrieved 15 July 2021.
- ^ a b "Scientific Advisory Board". Vaccitech. Retrieved 15 July 2021.
- ^ "Jerome Kim Named to Head South Korea's International Vaccine Institute". John A. Burns School of Medicine. Retrieved 15 July 2021.
- ^ "Jerome Kim". Google Scholar. Retrieved 13 November 2023.
| Authority control databases: Academics |
|---|
 | This biographical article related to medicine is a stub. You can help Wikipedia by expanding it. |